bluebird bio Inc (NASDAQ: BLUE) stock closed at $3.42 on 11/17/23 after a major increase of 12.5%. The stock has risen 12.7% during the last week but has been weak relative to the market over the last nine months.
Current PriceTarget Research Rating
With future capital returns forecasted to be in line with the cost of capital, BLUE is expected to continue to be Value Creation neutral.
bluebird bio has a current Value Trend Rating of F (Lowest Rating). With this rating, PTR’s two proprietary measures of a stock’s current attractiveness are providing complementary signals. bluebird bio has a slightly negative Power Rating of 31 and a very low Appreciation Score of 6, leading to the Lowest Value Trend Rating.
Rating Review
In light of this very positive price change we are reviewing our current Overall Rating of F. This review will be completed in the next several days.
Be the first to comment